
FDA’s Rejection of MDMA-Assisted Therapy for PTSD: A Setback for Innovation and Healing
The FDA’s rejection of MDMA-assisted therapy for PTSD represents a missed opportunity to advance innovative treatments that could provide significant relief to those suffering from the condition. In a disappointing turn of events, the U.S.